Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Relative Value
The Relative Value of one Shijiazhuang Yiling Pharmaceutical Co Ltd stock under the Base Case scenario is 27.26 CNY. Compared to the current market price of 18.16 CNY, Shijiazhuang Yiling Pharmaceutical Co Ltd is Undervalued by 33%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Shijiazhuang Yiling Pharmaceutical Co Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
CN |
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
|
30.3B CNY | 3.4 | 66.9 | 46.4 | 46.4 | ||
JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | 4 211 733 | -5 347 888.9 | -5 459 134.4 | -5 046 864.6 | |
US |
Eli Lilly and Co
NYSE:LLY
|
779.7B USD | 21.7 | 127 | 62.1 | 70.7 | ||
DK |
Novo Nordisk A/S
CSE:NOVO B
|
4.1T DKK | 16.9 | 46.3 | 34.5 | 37.9 | ||
UK |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 | -15 783.5 | 3 846.3 | 17 702.3 | ||
US |
Johnson & Johnson
NYSE:JNJ
|
353B USD | 4.1 | 9.2 | 11.3 | 14.8 | ||
US |
Merck & Co Inc
NYSE:MRK
|
318B USD | 5.2 | 137.9 | 34.4 | 56.2 | ||
UK |
AstraZeneca PLC
LSE:AZN
|
189B GBP | 5.1 | 38 | 175.1 | 278.7 | ||
CH |
Roche Holding AG
SIX:ROG
|
184.2B CHF | 3.1 | 16 | 9.1 | 10.8 | ||
CH |
Novartis AG
SIX:NOVN
|
182.3B CHF | 3.4 | 11.5 | 8.8 | 12.8 | ||
US |
Pfizer Inc
NYSE:PFE
|
162.4B USD | 2.9 | -525.6 | 12.7 | 20.6 |